Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
J Immunol ; 163(4): 1984-90, 1999 Aug 15.
Article in English | MEDLINE | ID: mdl-10438935

ABSTRACT

The trafficking of leukocytes through tissues is supported by an interaction between the beta 2 (CD18) integrins CD11a/CD18 (LFA-1) and CD11b/CD18 (Mac-1) and their ligand ICAM-1. The most recently identified and fourth member of the beta 2 integrins, alpha D beta 2, selectively binds ICAM-3 and does not appear to bind ICAM-1. We have reported recently that alpha D beta 2 can support eosinophil adhesion to VCAM-1. Here we demonstrate that expression of alpha D beta 2 in a lymphoid cell that does not express alpha 4 integrins confers efficient binding to VCAM-1. In addition, a soluble form of alpha D beta 2 binds VCAM-1 with greater efficiency relative to ICAM-3. The I domain of alpha D contains a binding site for VCAM-1 since recombinant alpha D I domain binds specifically to VCAM-1. In addition, alpha D mAb that block cellular binding to VCAM-1 bind the alpha D I domain. Using VCAM-1 mutants we have determined that the binding site on VCAM-1 for alpha D beta 2 overlaps with that of alpha 4++ integrins. Substitution of VCAM-1 aspartate at position 40, D40, within the conserved integrin binding site, diminishes binding to alpha D beta 2 and abrogates binding to the alpha D I domain. The corresponding integrin binding site residue in ICAM-3 is also essential to alpha D beta 2 binding. Finally, we demonstrate that alpha D beta 2 can support lymphoid cell adhesion to VCAM-1 under flow conditions at levels equivalent to those mediated by alpha 4 beta 1. These results indicate that VCAM-1 can bind to an I domain and that the binding of alpha D beta 2 to VCAM-1 may contribute to the trafficking of a subpopulation of leukocytes that express alpha D beta 2.


Subject(s)
Integrins/metabolism , Leukocytes/metabolism , Peptide Fragments/metabolism , Receptors, Cytoadhesin , Vascular Cell Adhesion Molecule-1/metabolism , Animals , Antibodies, Blocking/metabolism , Antibodies, Monoclonal/metabolism , Antigens, CD/genetics , Antigens, CD/metabolism , Binding Sites/genetics , Binding Sites/immunology , Binding Sites, Antibody , CD11 Antigens , Cell Adhesion/immunology , Cell Movement/immunology , Humans , Integrin alpha Chains , Integrin alpha4 , Integrins/biosynthesis , Integrins/genetics , Integrins/immunology , Jurkat Cells , Leukocytes/immunology , Mice , Mice, Inbred BALB C , Peptide Fragments/chemistry , Peptide Fragments/genetics , Protein Binding/genetics , Protein Binding/immunology , Recombinant Proteins/metabolism , Rheology
2.
J Leukoc Biol ; 65(6): 867-74, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10380912

ABSTRACT

ICAM-3 is a pan-hematopoietic, constitutive adhesion molecule. ICAM-3 binds to LFA-1 on antigen-presenting cells (APC) stabilizing the T cell-APC interaction, facilitating signaling through the CD3/TCR complex. However, recent evidence using cultured and transformed T cells suggests ICAM-3 may also function in signaling. Because ICAM-3 is constitutively expressed on resting T cells, we postulated that signaling through ICAM-3 in resting T cells represents an important costimulatory mechanism in these cells. In purified resting human T cells, cross-linking both ICAM-3 and CD3 with plate-bound antibodies resulted in a marked increase in cell size (consistent with blastogenesis), synergistically increased surface expression of CD25 and CD69, and increased T cell metabolism. Similarly, concomitant ICAM-3 and CD3 stimulation significantly (P < 0.001) increased resting human T cell phosphatidylinositol hydrolysis and phospholipase C-gamma1 phosphorylation. These results indicate that ICAM-3 augments signaling through CD3, functioning as a costimulatory molecule for resting T cells in the initial activation step.


Subject(s)
Antigens, CD , Antigens, Differentiation , CD3 Complex/immunology , Cell Adhesion Molecules/metabolism , Cross-Linking Reagents/metabolism , T-Lymphocytes/immunology , Cross-Linking Reagents/pharmacology , Humans , Hydrolysis , Lymphocyte Activation/immunology , Membrane Potentials , Phosphatidylinositols/metabolism , Phosphorylation , Signal Transduction/drug effects , T-Lymphocytes/physiology , Type C Phospholipases/metabolism
3.
J Exp Med ; 188(11): 2187-91, 1998 Dec 07.
Article in English | MEDLINE | ID: mdl-9841932

ABSTRACT

The beta2 family of integrins, CD11a, CD11b, CD11c, and alphad, are expressed on most leukocytes. We show that the newest member of this family, alphad, is expressed on human eosinophils in peripheral blood, and surface expression can be upregulated within minutes by phorbol ester or calcium ionophore A23187. Culture of eosinophils with interleukin 5 (IL-5) leads to a two- to fourfold increase in alphad levels by 3-7 d without a change in alpha4 integrin expression. Eosinophils isolated from late phase bronchoalveolar lavage fluids express alphad at levels similar to that seen after 3 d of IL-5 culture. Regarding alphadbeta2 ligands, in both freshly isolated and IL-5-cultured eosinophils, as well as alphadbeta2-transfected Chinese hamster ovary cells, alphadbeta2 can function as a ligand for vascular cell adhesion molecule 1 (VCAM-1). This conclusion is based on the ability of monoclonal antibodies to alphad, beta2, or VCAM-1 to block cell attachment in static adhesion assays. In experiments with eosinophils, the relative contribution of alphadbeta2 integrin- mediated adhesion is enhanced after IL-5 culture. These experiments demonstrate that alphadbeta2 is an alternative ligand for VCAM-1, and this integrin may play a role in eosinophil adhesion to VCAM-1 in states of chronic inflammation.


Subject(s)
Eosinophils/metabolism , Integrins/metabolism , Receptors, Cytoadhesin , Vascular Cell Adhesion Molecule-1/metabolism , Animals , CD11 Antigens , Cell Adhesion , Cricetinae , Eosinophils/cytology , Eosinophils/immunology , Humans , Integrin alpha Chains , Ligands
4.
J Immunol ; 160(11): 5579-87, 1998 Jun 01.
Article in English | MEDLINE | ID: mdl-9605163

ABSTRACT

ICAM-3 is expressed at high levels on myeloid leukocytes, but its function on these cells is unknown. We tested the hypothesis that it transduces outside-in proinflammatory signals using immobilized mAbs to engage ICAM-3 on freshly isolated human monocytes and neutrophils. Two immobilized Abs that recognize epitopes in the extracellular domain 1 of ICAM-3, which is critical for recognition by the alphaL/beta2 integrin, potently induced secretion of MIP-1alpha, IL-8, and MCP-1 by monocytes and triggered IL-8 secretion by neutrophils. These chemokines are products of immediate-early genes that are induced when myeloid cells are activated. Chemokine secretion induced by "triggering" Abs was greater than that induced by isotype-matched immobilized Abs against ICAM-1, ICAM-2, PECAM-1, control Igs, or immobilized control proteins. Coengagement of ICAM-3 and Fc receptors (FcgammaRI or FcgammaRII) was required for maximal chemokine secretion by monocytes. Microscopy documented that there is also dramatic spreading of monocytes when surface ICAM-3 is engaged by immobilized Abs. Spreading was induced by Fab and F(ab')2 fragments of triggering anti-ICAM-3 mAb, demonstrating direct outside-in signaling, but was not required for chemokine secretion. These experiments indicate that ICAM-3 may transmit outside-in signals when it is engaged by beta2 integrins during myeloid cell-cell interactions in inflammatory lesions. Binding of Fc receptors by Ig in the local environment can amplify the responses.


Subject(s)
Antigens, CD , Antigens, Differentiation , Cell Adhesion Molecules/metabolism , Cell Movement/immunology , Chemokines/metabolism , Monocytes/metabolism , Neutrophils/metabolism , Receptors, Fc/metabolism , Adult , Antibodies, Monoclonal/pharmacology , Cell Adhesion Molecules/immunology , Humans , Monocytes/immunology , Neutrophils/immunology , Signal Transduction/immunology
5.
Stroke ; 28(10): 2031-7; discussion 2037-8, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9341715

ABSTRACT

BACKGROUND AND PURPOSE: Inflammation may play a role in delayed chronic vasospasm after aneurysmal subarachnoid hemorrhage. We investigated the role of intercellular adhesion molecule-1 (ICAM-1) and macrophage/granulocyte infiltration in the rat femoral artery model of vasospasm using systemic administration of a murine anti-ICAM-1 monoclonal antibody (MAb). METHODS: The femoral arteries (n = 72) in Sprague-Dawley rats (n = 36) were enclosed in latex pouches bilaterally. Autologous blood was injected into the pouch on one side, and saline was injected on the contralateral side. Chronic vessel narrowing was evaluated with the use of 29 rats, which were randomized into one of three groups for intraperitoneal injections: (1) anti-ICAM-1 MAb (2 mg/kg per dose, n = 10), (2) isotype-matched MAb (2 mg/kg per dose, n = 9), or (3) saline (n = 10), given at 3 hours and 3, 6, and 9 days after blood exposure. These rats were killed 12 days after blood exposure, and femoral artery lumen cross-sectional areas were determined by computerized image analysis. Saturation of ICAM-1 binding sites with this dosing schedule was evaluated by fluorescence-activated cell sorter (FACS) analysis of splenocytes. Immunohistochemical studies with objective cell counts were performed to evaluate macrophage/granulocyte infiltration at 24 hours in 7 rats, comparing anti-ICAM-1 MAb treatment (n = 4) with isotype-matched control MAb (n = 3). RESULTS: Animals treated with anti-ICAM-1 MAb showed a significant inhibition of arterial narrowing at 12 days (P = .0081), with lumen patency of 96.5 +/- 5.3% (mean +/- SEM), compared with 77.3 +/- 5.6% for isotype-matched MAb and 72.2 +/- 5.3% for saline-treated controls. FACS analysis of splenocytes from animals treated with anti-ICAM-1 MAb confirmed saturation of ICAM-1 binding sites. Vessels treated with anti-ICAM-1 MAb showed a significant decrease in inflammatory cell infiltrates, with objective macrophage/granulocyte counts of 31.3 +/- 26.6 (mean +/- SEM) per high-powered field, compared with 171.4 +/- 30.7 for isotype-matched control MAb (P = .0027). CONCLUSIONS: Anti-ICAM-1 MAb administered systemically starting 3 hours after blood exposure results in significant inhibition of chronic vasospasm in the rat femoral artery model and is correlated with a reduction in the number of infiltrating macrophages and granulocytes in the periadventitial region of blood-exposed arteries. We conclude that inflammatory changes associated with ICAM-1-mediated macrophage and granulocyte migration play an important role in the development of posthemorrhagic chronic vasospasm in this model.


Subject(s)
Antibodies, Monoclonal/pharmacology , Intercellular Adhesion Molecule-1/immunology , Vasoconstriction/drug effects , Animals , Blood Physiological Phenomena , Cell Separation , Femoral Artery/metabolism , Femoral Artery/pathology , Flow Cytometry , Granulocytes/pathology , Immunohistochemistry/methods , Intercellular Adhesion Molecule-1/metabolism , Macrophages/pathology , Male , Mice , Mice, Inbred BALB C , Rats , Rats, Sprague-Dawley , Spleen/immunology , Spleen/pathology , Staining and Labeling , Vasoconstriction/physiology
7.
J Neuropathol Exp Neurol ; 55(10): 1060-72, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8858003

ABSTRACT

To identify potential molecular substrates for leukocyte trafficking and activation in multiple sclerosis (MS) brain, we determined the immunocytochemical distribution of the beta, integrin lymphocyte-function-associated antigen-1 (LFA-1) and its major ligands, intercellular adhesion molecule (ICAM)-1, ICAM-2, and ICAM-3 in MS tissue. Colocalization of these adhesion molecules with lineage-specific markers was analyzed by dual-labeling immunocytochemistry and confocal microscopy. ICAM-1 and ICAM-2 were detected on endothelial cells, and ICAM-3 immunoreactivity was restricted to infiltrating leukocytes. In control brain, 10% of glucose transporter-1 positive vessels contained ICAM-1 immunoreactivity on their luminal surface and 21% were ICAM-2-positive. A significant increase in ICAM-1-positive vessels was found in MS brains. This increase was greater in MS lesions (81% of vessels) than in nonlesion areas (37% of vessels). A significant increase in ICAM-1-positive vessels was found in encephalitis (55% of vessels) but not in Parkinson's (17% of vessels) brains. The percentage of vessels expressing ICAM-2 was not increased in MS, encephalitis, or Parkinson's brains. Both ICAM-3 and LFA-1 were detected on the vast majority of infiltrating lymphocytes and monocytes in and near MS lesions, and these cells were often closely apposed to each other. In addition, LFA-1 was detected on activated microglia located close to the edge of demyelinating lesions. ICAM-3-positive leukocytes were often closely apposed to LFA-1-positive microglia. These results suggest a role for ICAM-1, -2, and LFA-1 in the transendothelial migration of leukocytes into MS brain and a role for ICAM 3/LFA-1 interactions in the activation of lymphocytes, monocytes, and microglia in MS lesions.


Subject(s)
Antigens, CD/analysis , Antigens, Differentiation , Brain Chemistry , Cell Adhesion Molecules/analysis , Intercellular Adhesion Molecule-1/analysis , Lymphocyte Function-Associated Antigen-1/analysis , Multiple Sclerosis/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Brain/cytology , Brain/immunology , Child , Child, Preschool , Endothelium/chemistry , Endothelium/cytology , Humans , Infant , Infant, Newborn , Leukocytes/chemistry , Microscopy, Confocal , Middle Aged , Multiple Sclerosis/immunology
9.
J Cell Biol ; 120(5): 1271-9, 1993 Mar.
Article in English | MEDLINE | ID: mdl-8094718

ABSTRACT

Receptor tyrosine kinases (RTKs) are grouped into subcategories based on shared sequence and structural features. Human group C adenoviruses down-regulate EGF receptors, which are members of the class I family of RTKs, during the early stages of infection. Adenovirus appears to utilize a nonsaturable intracellular pathway since it causes EGF-R down-regulation even in cells that significantly overexpress EGF-R. Adenovirus-induced down-regulation is mediated by a small hydrophobic molecule coded for by the E3 early transcription region that has recently been localized to plasma membrane. Here we examine intracellular trafficking of other RTKs in adenovirus-infected cells, to better understand the molecular basis for the action of the E3 protein. Although p185c-neu, which is a class I RTK closely related to the EGF receptor, is down-regulated in cells expressing physiological concentrations of this molecule, it is not down-regulated in tumor cell lines that significantly overexpress p185c-neu. Cell surface receptors for insulin and IGF1, which are class II RTKs, are also reduced in cells expressing the E3 protein, although to a slightly lesser extent than the EGF receptor. Moreover, whereas EGF receptors are degraded between 3- and 9-h postinfection, insulin and IGF1 receptors are degraded between 6- and 12-h postinfection under identical conditions. In contrast to the class I and class II RTKs, there is no difference in the expression of the class III receptors for PDGF and aFGF in cells infected with a virus with an intact E3 region versus a virus mutant with an internal deletion in the relevant E3 gene. These results suggest that the E3 protein provides an internalization and degradative sorting signal for some class I and class II RTKs, although down-regulation of class II RTKs is somewhat less efficient. Molecular recognition of class I and class II RTKs during adenovirus infection may not be due strictly to amino acid structure, however, since EGF-R but not p185c-neu is down-regulated in cells where it is significantly overexpressed.


Subject(s)
Adenovirus E3 Proteins/physiology , Adenovirus Infections, Human/metabolism , Adenoviruses, Human/genetics , Protein-Tyrosine Kinases/metabolism , Receptors, Cell Surface/metabolism , Cross-Linking Reagents , Down-Regulation , Epidermal Growth Factor/metabolism , ErbB Receptors/metabolism , Humans , In Vitro Techniques , Insulin/metabolism , Proto-Oncogene Proteins/metabolism , Receptor Aggregation , Receptor, ErbB-2 , Receptor, Insulin/metabolism , Receptors, Platelet-Derived Growth Factor/metabolism , Receptors, Somatomedin/metabolism , Receptors, Transferrin/metabolism , Time Factors , Tumor Cells, Cultured
10.
Nature ; 360(6403): 485-8, 1992 Dec 03.
Article in English | MEDLINE | ID: mdl-1448174

ABSTRACT

The human intercellular adhesion molecules ICAM-1, ICAM-2 and their counter-receptors, the beta 2 or leukointegrins, mediate a variety of homotypic and heterotypic leukocyte and endothelial cell-cell adhesions central to immunocompetence. It has been found that cell-cell adhesion which is dependent on expression of the leukocyte function-associated antigen LFA-1 is not always blocked completely by antibodies raised against ICAM-1 and ICAM-2. Other leukointegrin ligands therefore probably exist, such as a glycoprotein of M(r) 124K that binds LFA-1 and has been designated ICAM-3 on the basis of this function. We have molecularly cloned a new member of the ICAM family, ICAM-R, which is related to ICAM-1 and ICAM-2. The complementary DNA encoding ICAM-R is 1,781 base pairs long and the protein has five extracellular immunoglobulin-family type domains. The mature cell-surface form of the ICAM-R protein has an M(r) which varies from 116 to 140K in a cell type-specific fashion. Overall identities in protein sequence with ICAM-1 and ICAM-2 are 48% and 31% respectively, with the degree of similarity varying between individual domains. The high level of expression of ICAM-R on resting leukocytes of all lineages and its lack of expression on either resting or cytokine-activated endothelial cells indicates a pattern of expression distinct from ICAM-1 and ICAM-2. In common with ICAM-1 and ICAM-2, ICAM-R is a ligand for the beta 2-integrin CD11a/LFA-1 (CD18).


Subject(s)
Cell Adhesion Molecules , Cell Adhesion , DNA/genetics , Endothelium, Vascular/physiology , Leukocytes/physiology , Amino Acid Sequence , Animals , Antibodies, Monoclonal , Base Sequence , Cell Line , Cells, Cultured , Cloning, Molecular , DNA/isolation & purification , Flow Cytometry , Humans , L Cells , Mice , Models, Structural , Molecular Sequence Data , Oligodeoxyribonucleotides , Protein Conformation , RNA, Messenger/analysis , RNA, Messenger/metabolism , Transcription, Genetic , Transfection , Tumor Cells, Cultured
11.
Proc Natl Acad Sci U S A ; 86(12): 4654-8, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2471973

ABSTRACT

We have identified extensive structural homology between one type of heterotypic adhesion receptor (HAR) involved in lymphocyte interactions with high endothelium in lymphoid organs and a collagen-binding protein, termed class III extracellular matrix receptor (ECMRIII), expressed on most nucleated cell types. Both receptors have been described as heterogeneous 90-kDa transmembrane glycoproteins, referred to here as gp90. Monoclonal anti-HAR antibodies, Hermes-1 and Hutch-1, and monoclonal anti-ECMRIII antibodies, P1G12 and P3H9, were utilized to compare the two receptors. (i) All these monoclonal antibodies immunoprecipitated major gp90 components as well as uncharacterized additional higher molecular mass antigens of 120-200 kDa in human and macaque fibroblasts and peripheral blood mononuclear cells. (ii) Competitive binding analyses with the antibodies identified distinct epitopes present on gp90. (iii) Enzymatic and chemical digestions generated identical peptide fragments from all the antigens in human and macaque fibroblasts and peripheral blood mononuclear cells. (iv) Sequential immunoprecipitation with P1G12 followed by the other monoclonal antibodies indicated that all gp90 species reactive with Hermes-1 and Hutch-1 also expressed the P1G12 defined epitope. In reciprocal experiments, Hermes-1 and Hutch-1 immunoprecipitation did not completely remove all P1G12-reactive gp90 from cellular extracts. One inference from these data would be that gp90 is serologically heterogeneous, encompassing HARs as a major subset of this broadly expressed class of molecules.


Subject(s)
Epitopes/analysis , Extracellular Matrix/metabolism , Lymphocytes/metabolism , Receptors, Cell Surface/immunology , Receptors, Immunologic/immunology , Animals , Antibodies, Monoclonal , Cell Line , Humans , Macaca nemestrina , Molecular Weight , Peptide Fragments/analysis , Peptide Hydrolases , Receptors, Cell Surface/isolation & purification , Receptors, Cell Surface/metabolism , Receptors, Immunologic/isolation & purification , Receptors, Immunologic/metabolism , Receptors, Lymphocyte Homing , Structure-Activity Relationship
12.
Proc Natl Acad Sci U S A ; 86(9): 3301-5, 1989 May.
Article in English | MEDLINE | ID: mdl-2470099

ABSTRACT

Although all CD4+ cells theoretically are at risk for infection by human immunodeficiency viruses or the related simian immunodeficiency viruses found in Old World monkeys, only a small proportion of CD4+ lymphocytes from infected individuals have detectable virus. This suggests that immunodeficiency viruses may replicate predominantly in a minor subset or activated form of CD4+ T cells, a possibility we examined in macaques infected with a simian immunodeficiency virus isolate, SIV/Mne. Macaque CD4+ lymphocytes could be divided into two subtypes that differed in their level [high (hi) or low (lo)] of expression of a class of heterotypic adhesion receptors (HARs). In blood from animals infected with SIV/Mne, HARhi CD4+ T cells were lost selectively compared to HARlo CD4+ cells and, when cultured, exhibited 50-fold more recoverable reverse transcriptase activity. The HARhi CD4+ subset was also markedly more susceptible to productive infection following exposure to SIV/Mne in vitro. Both subsets are composed primarily of small resting lymphocytes. However, HARhi cells respond differentially to mitogenic stimulation and may thus be more likely to provide the cellular factors necessary to initiate or enhance virus replication. Thus, HAR expression may prove useful both as a prognostic indicator in immunodeficiency virus infection and as a tool to analyze pathogenesis of immunodeficiency viruses.


Subject(s)
Receptors, Immunologic/analysis , Simian Immunodeficiency Virus/physiology , T-Lymphocytes, Helper-Inducer/microbiology , Virus Replication , Animals , Antigens, Differentiation, T-Lymphocyte/analysis , Cell Adhesion , Cell Cycle , Cell Survival , Cells, Cultured , DNA/analysis , Flow Cytometry , Lymphocyte Activation , Macaca , Mitogens/pharmacology , Phenotype , RNA-Directed DNA Polymerase/metabolism , Receptors, Lymphocyte Homing , Retroviridae Infections/immunology , T-Lymphocytes, Helper-Inducer/analysis
13.
J Immunol ; 142(10): 3416-22, 1989 May 15.
Article in English | MEDLINE | ID: mdl-2785555

ABSTRACT

Glycoproteins of 90 to 95 kD Mr are involved in adhesion to high endothelium and migration into secondary lymphoid tissues in several species. Recent evidence indicates that in primates, one type of these molecules may be subsumed under the CD44 grouping of lymphocyte differentiation Ag. Flow cytometric analysis of circulating macaque lymphocytes for expression of these structures revealed a prominent bimodal distribution, defining two subpopulations with a 5- to 10-fold difference in immunofluorescence staining intensity. Studies of lymphocytes from different anatomic compartments revealed marked differences in the relative numbers of these two phenotypes: splenic and peripheral blood lymphocytes were mostly CD44hi, whereas thoracic duct lymphocytes, which have recently exited lymph nodes and Peyer's patches, were predominantly CD44lo, suggesting that these subsets may have different migratory behavior in vivo. Activated lymphocytes, as defined by light scatter measurements, expression of IL-2-R, and CD45R levels, were all CD44hi. Simultaneous three parameter flow cytometric determination of CD44 and CD45R expression, and cell-cycle analysis with 7-amino actinomycin D further demonstrated that intrinsically cycling cells were contained in the CD44hi, CD45R+ subset. After stimulation of CD44lo lymphocytes in vitro with cross-linked anti-CD3 antibodies and PMA, CD44 expression markedly increased. These data indicate that CD44 up-regulation is an early event in T lymphocyte activation in vivo, and support the hypothesis that patterns of lymphocyte traffic are regulated in concert with cell activation, possibly by differential expression of CD44.


Subject(s)
Antigens, Surface/analysis , Cell Adhesion , Cell Movement , Endothelium, Lymphatic/metabolism , Endothelium/metabolism , Lymphocyte Activation , Receptors, Immunologic/analysis , Animals , Antibodies, Monoclonal , Antigens, Differentiation/immunology , Antigens, Surface/immunology , Cell Adhesion Molecules , Endothelium, Lymphatic/immunology , Endothelium, Lymphatic/physiology , Female , Macaca nemestrina , Male , Phenotype , Receptors, Immunologic/immunology , T-Lymphocytes/classification
15.
Toxicon ; 21(3): 363-9, 1983.
Article in English | MEDLINE | ID: mdl-6623484

ABSTRACT

Chromatographically purified ciguatoxin from toxic blackfin snapper (Lutjanus buccanella) obtained from an impounded catch in the U.S. Virgin Islands was used together with a refined mouse bioassay to construct a dose-response curve. The LD50 was calculated to be 87 mg/kg and the range of ciguatoxin doses between 0% and 100% lethality was narrow (62.5-112.5 mg/kg). Symptoms appeared in a rather stereotypic pattern with the most frequent being lowered rectal temperature and reduced locomotor activity and reflexes. Diarrhea and cyanosis were common. Breathing difficulties and convulsions occurred more often at higher doses. Approximately one-half of the animals which succumbed to ciguatoxin showed convulsions at some time, often just prior to death. The mouse bioassay described permits a reproducible and moderately sensitive detection of ciguatoxicity and would, if uniformly adopted, facilitate a comparison among future reports on ciguatera research.


Subject(s)
Ciguatoxins/toxicity , Marine Toxins/toxicity , Animals , Biological Assay , Dose-Response Relationship, Drug , Female , Mice
SELECTION OF CITATIONS
SEARCH DETAIL
...